ChemNet > CAS > 540737-29-9 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
540737-29-9 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Featured China Suppliers
Ruiyixiang Hangzhou Imp. & Exp. Co., Ltd.
[ Gold Suppliers ]
| Telephone | +86-571-86919872 |
| gm@ryxchina.com | |
| Address | Room 911,Unit B3,Xihu International Science and Technology Building,No.391,Wener road,Xihu District,Hangzhou city,Zhejiang province,China. |
Hangzhou Pharma & Chem Co.,Ltd.
[ Gold Suppliers ]
| Contact | Mr.Chen |
| Telephone | +86-571-87040515 |
| chenhk@hzph.com | |
| Address | QinglianBldg.No,139QingchunRd,HangzhouCity,Zhejiang,China |
AFINE CHEMICALS LIMITED
[ Gold Suppliers ]
| Contact | Mr. Wei Fei ( Managing Director) Mrs. Lanny Cao ( Director) |
| Telephone | +86-571-85232125;85232161;85134551 |
| info@afinechem.com;sales@afinechem.com | |
| Address | 7-601 ,Xigang Xinjie, Xihu Industrial Park, Sandun Town,Hangzhou 310030, China |
Sinoway Industrial Co.LTD.
[ Gold Suppliers ]
| Specifications | 99% up, Medicine Grade |
| Packing | 25kg/drum |
| Description | Function of Tofacitinib Citrate 1. Rheumatoid arthritis (RA) Tofacitinib citrate is a new class of anti-rheumatic drugs approved by the US FDA for the first time in ten years. Compared with other traditional anti-rheumatic drugs, it can not only relieve symptoms, but also slow or stop disease damage. Its clinical therapeutic effect is also comparable to biological drugs such as adalimumab. So far, monoclonal antibodies or fusion proteins are the main clinical treatments for RA, which require injections, and tofacitinib has greater advantages as an oral drug. The results of clinical studies show that tofacitinib still has satisfactory clinical effects for RA patients whose treatment with biological agents is ineffective. Therefore, these studies have further established its therapeutic status in patients with moderate to severe RA. 2. Treatment of active psoriatic arthritis (PsA) In May 2017, the US FDA accepted the supplementary new drug application of Xeljanz and Xeljanz XR for th... |
| Contact | Xie Wen Feng |
| Telephone | +86-592-5881089 |
| xie@china-sinoway.com | |
| Address | 16/F,Huicheng Comm,Complex,No839 XiaHe Rd, Xiamen,China |
Chemvon Biotechnology Co., Ltd.
[ Gold Suppliers ]
| Description | It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and Russia, and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. molecular formula:C16H20N6O¡¤C6H8O7 molecular weight:504.5 |
| Contact | peter |
| Telephone | +86-21-50790412;86-21-31268550 |
| marketing@chemvon.com,chemvon@hotmail.com | |
| Address | Suite B-10#, 6999 Chuansha Road,Pudong District, Shanghai 201202, China |
- Chemicals Suppliers(17):
- 1Ruiyixiang Hangzhou Imp. & Exp. Co., Ltd.
- 2Hangzhou Pharma & Chem Co.,Ltd.
- 3AFINE CHEMICALS LIMITED
- 4Sinoway Industrial Co.LTD.
- 5Chemvon Biotechnology Co., Ltd.
- 6Capot Chemical Co., Ltd.
- 7Hangzhou Shuyuan Pharmaceutical Technology Co., Ltd.
- 8Beijing Lunarsun Pharmaceutical Co.Ltd.
- 9Changzhou Pharmaceutical Factory
- 10Beijing Mesochem Technology Co.,Ltd

EN
CN
CZ
DE
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR![540737-29-9 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)](https://images-a.chemnet.com/suppliers/chembase/777/2014777_1.gif)
